Ascendio

주식회사 아센디오 · KOSPI · 012170 · Industry: Motion picture, video and broadcast programme activities

Key metrics

Earnings

Revenue, Q3 2026₩3.9bn As of Sep 30, 2026 Source 1 ↗
Revenue QoQ+136.5% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Revenue YoY+70.0% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income, Q3 2026-₩1.2bn As of Sep 30, 2026 Source 1 ↗
Operating income QoQ-71.5% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗
Operating income YoY-167.3% As of Sep 30, 2026 Source 1 ↗, Source 2 ↗

Share buybacks

Buyback decided, last 3 months₩0 As of Nov 19, 2026
Buyback decided, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 3 months₩0 As of Nov 19, 2026
Shares acquired, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 3 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 3 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 3 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Buyback decided, last 12 months₩0 As of Nov 19, 2026
Buyback decided, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Shares acquired, last 12 months₩0 As of Nov 19, 2026
Shares acquired, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗
Treasury shares cancelled, last 12 months₩0 As of Nov 19, 2026
Treasury shares cancelled (number), last 12 months0 shares As of Nov 19, 2026
Treasury shares cancelled, last 12 months, % of shares0.0% As of Nov 19, 2026 Source 1 ↗

Potential dilution

CB/BW/EB issued, last 12 months₩0 As of Nov 19, 2026
Rights offering new shares, last 12 months20,095,943 shares As of Aug 14, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗
Potential new shares, last 12 months20,095,943 shares As of Aug 14, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗
Potential new shares, % of shares275.4% As of Aug 14, 2026 Source 1 ↗, Source 2 ↗, Source 3 ↗, Source 4 ↗
Conversion price adjustments, last 12 months0 As of Nov 19, 2026

Supply contracts

Supply contracts, last 12 months₩6.1bn As of Nov 17, 2026 Source 1 ↗, Source 2 ↗, Source 3, Source 4
Supply contracts vs prior-year revenue103.2% As of Nov 17, 2026 Source 1 ↗, Source 2 ↗, Source 3, Source 4
Contracts without a KRW amount0 contracts without a KRW amount excluded As of Nov 19, 2026

Disclosure activity

DART filings, last 3 months23 As of Nov 19, 2026
DART filings, previous 3 months39 As of Nov 19, 2026

Insider transactions

Open-market buys, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market buys, last 12 months (amount)₩0 As of Nov 19, 2026
Open-market sells, last 12 months (shares)0 shares As of Nov 19, 2026
Open-market sells, last 12 months (amount)₩0 As of Nov 19, 2026
Net open-market buying, last 12 months (shares)0 shares As of Nov 19, 2026
Insiders who bought, last 12 months0 As of Nov 19, 2026

Insider transactions (last 12 months)

Open-market buys: 0 shares (₩0). Open-market sells: 0 shares (₩0). Net open-market buying: 0 shares. Insiders who bought: 0.

Trade dateInsider (role)TypeSharesPriceAmount
Oct 14, 2026Eseutuinbeseuteumeonteu01 (10%+ shareholder)Other (Third-party placement)+2,442,776 shares₩2,665₩6.5bn
Aug 11, 2026KYUNGNAM PHARM.CO.,LTD (10%+ shareholder)Other (Third-party placement)+3,246,683 shares₩4,035₩13.1bn
Aug 8, 2026Kiwije1hojohap (10%+ shareholder)Other (Reverse split)-7,501,161 shares——
May 19, 2026Kiwije1hojohap (10%+ shareholder)Other (Third-party placement)+856,898 shares₩1,167₩1.0bn
Jan 17, 2026Kiwije1hojohap (10%+ shareholder)Other (Third-party placement)+8,519,553 shares₩1,432₩12.2bn

Annual financials

YearRevenueOperating income
2025₩5.9bn-₩4.3bn
2024₩13.5bn-₩4.1bn
2023₩6.9bn-₩10.4bn

Filing timeline